Try our beta test site
32 studies found for:    ironwood
Show Display Options
Rank Status Study
1 Not yet recruiting Study of IW-1701, A Stimulator of Soluble Guanylate Cyclase (sGC), in Patients With Type II Achalasia
Condition: Achalasia
Interventions: Drug: IW-1701;   Drug: Matching Placebo
2 Recruiting A Phase 2 Trial of IW-1973, A Stimulator of Soluble Guanylate Cyclase (sGC), in Patients With Stable Type 2 Diabetes and Hypertension
Conditions: Diabetes Mellitus, Type 2;   Hypertension
Interventions: Drug: Matching Placebo;   Drug: IW-1973
3 Not yet recruiting A Study of the Effect of Linaclotide on Abdominal Girth in Participants With IBS-C
Condition: Irritable Bowel Syndrome Characterized by Constipation
Interventions: Drug: Linaclotide;   Drug: Placebo
4 Completed A Trial of IW-1701, A Stimulator of Soluble Guanylate Cyclase (sGC), in Healthy Subjects
Condition: Healthy
Interventions: Drug: IW-1701;   Drug: Placebo
5 Active, not recruiting A Randomized, Double-blind, Placebo-controlled,Trial of IW-3718 for 8 Weeks in Patient With Symptomatic GERD
Condition: Gastroesophageal Reflux Disease
Interventions: Drug: IW-3718;   Drug: Matching Placebo
6 Completed Trial of IW-1973 (A Stimulator of Soluble Guanylate Cyclase (sGC)) in Healthy Volunteers
Condition: Healthy
Interventions: Drug: IW-1973;   Drug: Matching Placebo Tablet
7 Completed Trial of IW-1701 (A Stimulator of Soluble Guanylate Cyclase (sGC)) in Healthy Volunteers
Condition: Healthy
Interventions: Drug: IW-1701;   Drug: Matching Placebo
8 Completed Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Condition: Irritable Bowel Syndrome With Constipation
Interventions: Drug: Linaclotide;   Drug: Matching Placebo
9 Completed Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Condition: Chronic Idiopathic Constipation
Interventions: Drug: Linaclotide;   Drug: Matching Placebo
10 Completed Trial of IW-9179 in Patients With Diabetic Gastroparesis (DGP)
Condition: Diabetic Gastroparesis
Interventions: Drug: IW-9179;   Drug: Matching Placebo
11 Completed Ph2a Study to Evaluate IW-3718 in Patients With Gastroesophageal Reflux Not Completely Responsive to Proton Pump Inhibitors
Condition: Gastroesophageal Reflux
Interventions: Drug: IW-3718;   Drug: Matching Placebo
12 Terminated Phase 2a Study of IW-9179 to Treat Functional Dyspepsia
Conditions: Dyspepsia;   Functional Gastrointestinal Disorders
Interventions: Drug: IW-9179;   Drug: Placebo
13 Completed Study to Evaluate Efficacy and Safety of IW-6118 in Patients Undergoing Third Molar Extraction
Condition: Healthy
Interventions: Drug: IW-6118;   Drug: Matching Placebo;   Drug: Naproxen Sodium
14 Completed
Has Results
Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Condition: Irritable Bowel Syndrome With Constipation
Intervention: Drug: Linaclotide or Matching Placebo
15 Completed An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation
Conditions: Irritable Bowel Syndrome With Constipation;   Chronic Constipation
Intervention: Drug: Linaclotide
16 Completed
Has Results
Trial of Linaclotide in Patients With Chronic Constipation
Condition: Chronic Constipation
Interventions: Drug: Matching Placebo;   Drug: Linaclotide
17 Completed
Has Results
Randomized, Double-blind, Dose-range-finding, Phase 2 Study of Linaclotide Administered to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Condition: Irritable Bowel Syndrome With Constipation
Interventions: Drug: Linaclotide Acetate;   Drug: Matching placebo
18 Completed Study of Oral MD-0727 Administered to Patients With Primary Hypercholesterolemia
Condition: Hypercholesterolemia
Intervention: Drug: MD-0727
19 Completed
Has Results
Dose-range-finding, Phase 2 Trial of Oral Linaclotide Acetate Administered to Patients With Chronic Constipation
Condition: Chronic Constipation
Interventions: Drug: linaclotide acetate;   Drug: Matching placebo
20 Completed Phase 2 Study of MD-1100 Acetate Administered for 14 Days to Patients Meeting Criteria for Chronic Constipation
Condition: Constipation
Intervention: Drug: MD-1100 Acetate

   Previous Page Studies Shown (1-20) Next Page (21-32) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.